These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 7473180

  • 1. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.
    Millan MJ, Peglion JL, Vian J, Rivet JM, Brocco M, Gobert A, Newman-Tancredi A, Dacquet C, Bervoets K, Girardon S.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):885-98. PubMed ID: 7473180
    [Abstract] [Full Text] [Related]

  • 2. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A, Rivet JM, Audinot V, Cistarelli L, Spedding M, Vian J, Peglion JL, Millan MJ.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [Abstract] [Full Text] [Related]

  • 3. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [Abstract] [Full Text] [Related]

  • 4. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ, Audinot V, Melon C, Newman-Tancredi A.
    Eur J Pharmacol; 1995 Jul 04; 280(2):225-9. PubMed ID: 7589191
    [Abstract] [Full Text] [Related]

  • 5. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 04; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 6. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
    Millan MJ, Audinot V, Rivet JM, Gobert A, Vian J, Prost JF, Spedding M, Peglion JL.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):R3-5. PubMed ID: 7988633
    [Abstract] [Full Text] [Related]

  • 7. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
    Rivet JM, Audinot V, Gobert A, Peglion JL, Millan MJ.
    Eur J Pharmacol; 1994 Nov 24; 265(3):175-7. PubMed ID: 7875234
    [Abstract] [Full Text] [Related]

  • 8. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 24; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 9. Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
    Millan MJ, Rivet JM, Audinot V, Gobert A, Lejeune F, Brocco M, Newman-Tancredi A, Maurel-Remy S, Bervoets K.
    J Pharmacol Exp Ther; 1995 Jun 24; 273(3):1418-27. PubMed ID: 7791116
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec 24; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 11. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 24; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors.
    Millan MJ, Girardon S, Monneyron S, Dekeyne A.
    Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.
    Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, Boyfield I, Branch CL, Cilia J, Coldwell MC, Hadley MS, Hunter AJ, Jeffrey P, Jewitt F, Johnson CN, Jones DN, Medhurst AD, Middlemiss DN, Nash DJ, Riley GJ, Routledge C, Stemp G, Thewlis KM, Trail B, Vong AK, Hagan JJ.
    J Pharmacol Exp Ther; 2000 Sep 14; 294(3):1154-65. PubMed ID: 10945872
    [Abstract] [Full Text] [Related]

  • 14. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY.
    Pharmacol Biochem Behav; 2005 Oct 14; 82(2):361-72. PubMed ID: 16216322
    [Abstract] [Full Text] [Related]

  • 15. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G.
    J Pharmacol Exp Ther; 1994 Jan 14; 268(1):417-26. PubMed ID: 8301582
    [Abstract] [Full Text] [Related]

  • 16. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
    Millan MJ, Svenningsson P, Ashby CR, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A.
    J Pharmacol Exp Ther; 2008 Feb 14; 324(2):600-11. PubMed ID: 18024787
    [Abstract] [Full Text] [Related]

  • 17. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 14; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 18. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 14; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 19. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 14; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 14; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.